Vir Biotechnology rises after naming Theravance's Sawaf as CFO

** Vir Biotechnology's VIR.O shares rise more than 3% to $11.53 in afternoon trading

** Co appoints Aziz Sawaf as Chief Financial Officer effective Oct. 5

** Aziz joins from Theravance Biopharma, where he was CFO from 2023

** He is succeeding former CFO Jason O'Byrne, who left VIR on Aug. 3, to pursue another opportunity

** All 10 analysts covering VIR are bullish and their median PT is $20, according to data compiled by LSEG

** Including session moves, stock up 91% YTD